All Pharma News
price-trendAsk Us
Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma & Eidos

Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma & Eidos
BIOSPACE
04 Jan 2021
Share Share
BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement

BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement
GLOBENEWSWIRE
06 Oct 2020
Share Share
Eidos Therapeutics Appoints Industry Leaders With Significant DevelopmenT

Eidos Therapeutics Appoints Industry Leaders With Significant DevelopmenT
GLOBENEWSWIRE
07 Aug 2020
Share Share
BridgeBio scraps plan to buy Eidos after bids rebuffed

BridgeBio scraps plan to buy Eidos after bids rebuffed
N.P.Taylor FIERCE BIOTECH
15 Oct 2019
Share Share
Plotting toe-to-toe with Pfizer, Eidos plans score in PhIII ATTR-CM study

Plotting toe-to-toe with Pfizer, Eidos plans score in PhIII ATTR-CM study
John Carroll ENDPTS
28 Feb 2019
Share Share
EU green light for Cimzia to treat psoriasis

EU green light for Cimzia to treat psoriasis
Selina McKee PHARMA TIMES
03 Jul 2018
Share Share
Eidos Therapeutics raises $106M IPO to advance ATTR med

Eidos Therapeutics raises $106M IPO to advance ATTR med
Amirah Al Idrus FIERCE BIOTECH
20 Jun 2018
Share Share
Eidos Therapeutics Announces Pricing of Initial Public Offering

Eidos Therapeutics Announces Pricing of Initial Public Offering
PR NEWSWIRE
19 Jun 2018
Share Share
Rare disease biotech Eidos Therapeutics sets terms for $100 million IPO

Rare disease biotech Eidos Therapeutics sets terms for $100 million IPO
NASDAQ
08 Jun 2018
Share Share